Lacudex (Chlorhexidine Gluconate)

Chlorhexidine gluconate is a cationic bisbiguanide that binds to negatively charged bacterial cell walls, disrupting membrane integrity and precipitating intracellular contents, leading to cell death. Its broad‑spectrum activity covers Gram‑positive and Gram‑negative bacteria, fungi and some viruses, providing rapid antimicrobial action.

The dosage and frequency of Lacudex are determined by the prescribing clinician based on the specific indication, severity of infection risk, and patient factors. Healthcare providers select the appropriate amount and duration in accordance with local guidelines and product labeling.

Safety data for chlorhexidine gluconate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk, and the decision should be made by a qualified healthcare professional after evaluating the individual situation.

To place an order, submit an enquiry on the Lacudex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacudex’s active ingredient, chlorhexidine gluconate, offers a broader antimicrobial spectrum and longer residual activity compared with many povidone‑iodine or simple alcohol‑based preparations. It is well‑tolerated when used as directed, though individual tolerance may vary.

Store Lacudex at room temperature, below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme temperatures that could affect its stability.

Lacudex is applied intravaginally, typically using a pre‑filled applicator or measured dose as instructed by a healthcare professional. The product should be introduced gently into the vaginal canal, avoiding contact with the external genital skin unless directed otherwise.

The most serious risks include allergic reactions such as rash, hives, swelling, or anaphylaxis, and severe local irritation that may lead to ulceration. Immediate medical attention is required if any signs of a severe reaction occur.

Individuals with a known hypersensitivity to chlorhexidine or any component of the formulation should avoid Lacudex. It is also contraindicated in patients where the vaginal mucosa is severely damaged or ulcerated until the underlying condition is resolved.